$2.1B Endocyte Deal a Record-Breaker

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)
WEST LAFAYETTE -

A veteran of Indiana's life sciences industry says the proposed blockbuster sale of West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is good for the ecosystem in the state. Switzerland-based Novartis AG has signed an agreement to acquire Endocyte for $2.1 billion, which BioCrossroads Project Director Brian Stemme says is "by far" the largest-ever acquisition of an Indiana life sciences company. The deal still faces regulatory and shareholder hurdles.

In an interview with Inside INdiana Business, Stemme said the deal is validation of more than 20 years of support and determination. The company was born in the mid-1990s from biotechnology developed at Purdue University by eventual founder Philip Low and fellow biochemist Christopher Leamon. Low serves as chief science officer and Leamon is vice president of research and development.

"There's been just a lot of people between Dr. Low, Purdue University, the state of Indiana, all the executives and scientists that have been supporting that company over the years, so to see it really be recognized and work with a company that can help get that product to market, it's exciting," Stemme said. "It's a validation that all those folks knew what they were doing, knew what they were talking about, they saw the promise of that technology early and then just kept on grinding."

Stemme says the deal adds to some $8 billion in transactions involving Hoosier life sciences businesses in the last five years, including:

Endocyte is based at Purdue Research Park in West Lafayette, and last month, it was recognized as the first Purdue startup to be valued at $1.5 billion. Purdue President Mitch Daniels says "the sale of Endocyte is a landmark moment, but given the explosion in entrepreneurship and new start-ups at Purdue, I'm sure it's the first of many to come. "We are so deeply proud of our Purdue scientists whose genius is saving lives from cancer, and now has brought great new wealth to Indiana."

Last year, the company acquired a promising prostate cancer therapy in the late stages of development from ABX GmbH in Germany. Endocyte says it expects the acquisition will boost the chances of PSMA-617 going to market. Endocyte went public in 2011, raising $79 million during its initial public offering.

BioCrossroads Project Director Brian Stemme said the deal is validation of more than 20 years of support and determination.
  • Perspectives

    • Leaders Know How to Set the PACE

      Whether or not you’re a fan, you are probably familiar with the most important car in the starting field of most any major race event.  It’s the one car at the beginning of the race, the pace car, that provides the most important lessons since it plays a vital role in leading the way and helping the race get off to the appropriate start. There’s a lot for leaders to learn from that role. Having led countless nonprofits and business teams, and now consulting...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • (Image courtesy of the Indianapolis Colts.)

      Colts Announce Training Schedule, Title Sponsor

      The Indianapolis Colts and the city of Westfield have unveiled the schedule for the team's 2019 training camp at Grand Park Sports Campus. The camp will be held for the second time at the venue as part of a 10-year partnership announced last year. The team also announced the camp's title sponsor will be Indianapolis tech company...

    • TechPoint CEO Mike Langellier is among the event's speakers.

      New Partnership Goes on the Hunt for Tech Talent

      A new effort to attract top tech talent has launched in Indiana. TechPoint, the state's technology accelerator, is teaming up with Indianapolis-based TMap LLC, to find former Hoosiers currently working out of state in the tech industry and bring them back to Indiana. Through the initiative, the partners will identify the top 25 applicants who will be invited to a red carpet weekend this fall that will feature meetings with potential employers and events showcasing quality of life...
    • (photo courtesy of Dan McGowan)

      Senate Study Committee Assignments Revealed

      Indiana Senate President Pro Tempore Rodric Bray (R-Martinsville) has announced the interim study committee assignments for 2019. The interim study committees are set to meet this summer and fall to discuss a variety of topics ahead of the 2020 Indiana General Assembly.

    • (photo courtesy of the Indiana State Teachers Association)

      Former ISTA President Dies

      The former president of the Indiana State Teachers Association has died. Nate Schnellenberger began working with the ISTA in 1987 and was elected president in 2007, a role he held for six years. He was 68.

    • KSM Consulting Acquires Web Development Company

      Indianapolis-based KSM Consulting is adding to its portfolio. The firm, which specializes in technology, data analytics and management consulting, has acquired Connect Think, an app development company also based in Indy. Financial terms of the deal are not being disclosed.